Session Type
Date Time

It is recognized that the nature and intensity of HIV-related stigma may be exacerbated by interlocking structural determinants of health including systemic racism, sexism, transphobia, heterosexism/homophobia, neocolonialism, ageism, and xenophobia. Co-morbidities, such as mental health conditions and substance use disorders, further complicate enacted and experienced stigma and discrimination. HIV-related stigma and discrimination intersects with multiple interdependent aspects of life, social identities, and societal positions; however, our understanding of intersectionality within the context of HIV remains limited. There is, therefore, a critical need to disseminate the latest scientific findings to the field at AIDS 2022, the 24th International AIDS Conference (July 29th – August 2nd) in Montreal, Canada (and virtually). The NIH Office of AIDS Research (NIH OAR) and the National Institute of Mental Health (NIMH) are co-sponsoring a special issue in the American Journal of Public Health (AJPH) to be published online June 2022. The Special Issue will feature commentaries, editorials, original research, and systematic reviews to: (1) highlight innovative theory and research on intersectional stigma/discrimination in the context of HIV; and (2) encourage readers, practitioners, researchers, and policy makers to consider more fully the implications of the intersectional stigma for people living with and most affected by HIV and for the programs that serve them. The NIH recognizes the impact of HIV-related intersectional stigma/discrimination in the context of HIV and in the context of the current COVID-19 pandemic and other global challenges. To promote HIV research and inform Ending the HIV Epidemic (EHE), NIH OAR and NIMH convened researchers, government officials and community partners to engage in a three-phase virtual workshop process (July through September 2020) designed to: (1) Develop a common understanding of the concept of intersectional stigma and discrimination within the context of HIV prevention, treatment, and care; (2) Harmonize methods and measurements of intersectional stigma and discrimination; (3) Identify opportunities within, across, and beyond EHE jurisdictions to monitor intersectional stigma and discrimination; (4) Highlight the evidence-base of current interventions designed to reduce intersectional stigma and discrimination; (5) Integrate and tailor intersectional interventions to advance EHE goals and improve HIV prevention and treatment outcomes; and (6) Outline next steps to address research opportunities and to advance implementation plans. Based on workshop outcomes and the Special Issue, the Satellite Symposium will showcase a series of articles that highlight key HIV-related intersectional stigma topics and research advances. It will include NIH speakers, AJPH guest editors, and select authors. Preference has been given to articles authored by inter-disciplinary research teams, including community partners.

5 min
NIH Welcome
Dianne RAUSCH, NIMH, United States
Maureen M. GOODENOW, National Institutes of Health, United States
5 min
U.S. White House Office of National AIDS Policy
Harold PHILLIPS, White House, United States
10 min
Session Introduction - AJPH Guest Editors
Carmen LOGIE, University of Toronto, Canada
Sannisha DALE, University of Miami, United States
55 min
Presentations and Panel Discussion from AJPH Special Issue Authors
Arnetta PHILLIPS, University of Miami, United States
Andrew SPIELDENNER, MPact Global Action, United States
Tonia POTEAT, University of North Carolina, United States
Carmen LOGIE, University of Toronto, Canada
Sannisha DALE, University of Miami, United States
Daniel DRIFFIN, HVTN/ CoVPN at Fred Hutch, United States
Cristina RODRIGUEZ-HART, New York City Department of Health and Mental Hygiene, United States
10 min
Closing Remarks - AJPH Guest Editors
Carmen LOGIE, University of Toronto, Canada
Sannisha DALE, University of Miami, United States
5 min
Closing Remarks - NIH
Paul GAIST, National Institutes of Health Office of AIDS Research, United States
Amber WILSON, National Institute of Health (Office of Aids Research), United States
Gregory GREENWOOD, National Institute of Mental Health, United States